secwatch.observer — SEC 8-K summary
======================================

Issuer:     Werewolf Therapeutics, Inc. (HOWL)
CIK:        0001785530
Form:       8-K
Filed at:   2024-02-09T23:59:59+00:00
Accession:  0001193125-24-030144
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Werewolf Therapeutics files prospectus supplement for up to $25M ATM offering
-----------------------------------------------------------------------------

- Prospectus supplement filed to sell up to $25M of common stock via Leerink Partners.
- Prior $50M ATM program fully exhausted, generating ~$50M in gross proceeds.
- Shares outstanding as of Jan 31, 2024: 40,660,732.
- Legal opinion from Wilmer Cutler Pickering Hale and Dorr attached as Exhibit 5.1.
- Supplement under existing shelf registration (File 333-264844) declared effective May 20, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785530/000119312524030144/0001193125-24-030144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785530/000119312524030144/d772199d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-030144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer